Related Experiment Videos
Clindamycin enhances murine delayed-type hypersensitivity and anti-candidal activity
D J Kitz1, H R Neuman, J R Little
1Department of Biological Sciences, Southern Illinois University, Edwardsville 62026-1651.
Abstract:
The contact sensitivity response of mice to dinitrofluorobenzene (DNFB), as determined by an epicutaneous painting and subsequent ear challenge assay, was enhanced by clindamycin administration. The optimal augmentation effect of clindamycin required its simultaneous administration at the time of DNFB skin sensitization. Clindamycin also was found to boost both in-vitro and in-vivo murine response to experimental infection with Candida lusitaniae. Intraperitoneal injection of 1-2 mg of the drug increased the clearance of yeast from organs after intravenous inoculation of mice. Clindamycin at concentrations of as low as 12.5 mg/l also increased the ability of cultured murine macrophages to kill the yeast without an increase in phagocytic activity.
Insights
Clindamycin boosts immune responses in mice. This antibiotic enhanced contact sensitivity to dinitrofluorobenzene (DNFB) and improved the clearance of Candida lusitaniae infections.
Area of Science:
- Immunology
- Microbiology
- Pharmacology
Background:
- Clindamycin is an antibiotic with known immunomodulatory effects.
- The impact of clindamycin on specific immune responses like contact sensitivity and fungal infections requires further elucidation.
Purpose of the Study:
- To investigate the effect of clindamycin on dinitrofluorobenzene (DNFB)-induced contact sensitivity in mice.
- To evaluate clindamycin's efficacy in modulating murine responses to experimental Candida lusitaniae infection.
Main Methods:
- Contact sensitivity was assessed using an epicutaneous painting and ear challenge assay in mice.
- Murine models of Candida lusitaniae infection were established via intravenous inoculation.
- In vitro assays examined the effect of clindamycin on macrophage phagocytic and killing activity.
Main Results:
- Clindamycin administration significantly enhanced the contact sensitivity response to DNFB.
- Optimal enhancement of DNFB sensitivity occurred when clindamycin was given concurrently with sensitization.
- Clindamycin treatment improved the clearance of Candida lusitaniae from organs in infected mice.
- In vitro, clindamycin augmented the yeast-killing capacity of murine macrophages without increasing phagocytosis.
Conclusions:
- Clindamycin potentiates specific immune responses in mice, including contact hypersensitivity and antifungal immunity.
- The findings suggest clindamycin may have broader immunomodulatory applications beyond its antimicrobial properties.